Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate (Q73401217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

J A Lyons

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P A Kupelian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D S Mohan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E A Klein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

85-90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

External beam radiotherapy dose response of prostate cancer

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Androgen ablation in addition to radiation therapy for prostate cancer: is there true benefit?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900380-5

7 January 2021

10.1016/S0090-4295(99)00380-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10654900%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference